AAAAAA
Results: 51-57/57
Authors:
MOORE DF
PAZDUR R
ABBRUZZESE JL
Citation: Df. Moore et al., PHASE-II TRIAL OF INTRAVENOUS MELPHALAN IN ADVANCED COLORECTAL-CARCINOMA, Investigational new drugs, 12(2), 1994, pp. 133-136
Authors:
FUHRMAN GM
CHARNSANGAVEJ C
ABBRUZZESE JL
CLEARY KR
MARTIN RG
FENOGLIO CJ
EVANS DB
Citation: Gm. Fuhrman et al., THIN-SECTION CONTRAST-ENHANCED COMPUTED-TOMOGRAPHY ACCURATELY PREDICTS THE RESECTABILITY OF MALIGNANT PANCREATIC NEOPLASMS, The American journal of surgery, 167(1), 1994, pp. 104-113
Authors:
LENZI R
RABER MN
FROST P
SCHMIDT S
ABBRUZZESE JL
Citation: R. Lenzi et al., PHASE-II STUDY OF CISPLATIN, 5-FLUOROURACIL AND FOLINIC ACID IN PATIENTS WITH CARCINOMA OF UNKNOWN PRIMARY ORIGIN, European journal of cancer, 29A(11), 1993, pp. 1634-1634
Authors:
LEEJACKSON D
ABBRUZZESE JL
BARELI M
Citation: D. Leejackson et al., ARTIFACTUAL FRAME-SHIFT P53 MUTATION AT CODON-249 DETECTED WITH THE CYCLIST(TM) DNA-SEQUENCING METHOD, BioTechniques, 15(3), 1993, pp. 363-364
Authors:
BARELI M
ABBRUZZESE JL
LEEJACKSON D
FROST P
Citation: M. Bareli et al., P53 GENE MUTATION SPECTRUM IN HUMAN UNKNOWN PRIMARY TUMORS, Anticancer research, 13(5A), 1993, pp. 1619-1623
Authors:
AJANI JA
ABBRUZZESE JL
MARKOWITZ AB
PATT YZ
DAUGHERTY K
Citation: Ja. Ajani et al., PHASE-II STUDY OF ETOPOSIDE AND ALPHA-INTERFERON IN PATIENTS WITH ADVANCED MEASURABLE COLORECTAL-CARCINOMA, Investigational new drugs, 11(1), 1993, pp. 67-69
Authors:
ABBRUZZESE JL
LENZI R
RABER MN
PATHAK S
FROST P
Citation: Jl. Abbruzzese et al., THE BIOLOGY OF UNKNOWN PRIMARY TUMORS, Seminars in oncology, 20(3), 1993, pp. 238-243